Related Experiment Video

Updated: Sep 21, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

[Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell]

Y Yuan1, D L Xu, Y L Liu

  • 1Department of Cardiology, Nanfang Hospital, First Military Medical University, Guangzhou 510515.

Sheng Li Xue Bao : [Acta Physiologica Sinica]
|August 14, 2001
PubMed

Insights

Platelet-derived growth factor BB (PDGF-BB) significantly inhibits p27 expression, promoting vascular smooth muscle cell (VSMC) hyperplasia. Angiotensin II (Ang II) causes VSMC hypertrophy without affecting p27 levels, while arginine vasopressin (AVP) slightly downregulates it.

Area of Science:

  • Cardiovascular Biology
  • Cell Cycle Regulation
  • Molecular Biology

Background:

  • Vascular smooth muscle cells (VSMCs) play a crucial role in cardiovascular health.
  • Dysregulation of VSMC proliferation and hypertrophy contributes to vascular diseases.
  • Understanding the molecular mechanisms controlling VSMC cell cycle progression is essential.

Purpose of the Study:

  • To investigate the effects of key vasoactive peptides on VSMC cell cycle distribution.
  • To examine the impact of platelet-derived growth factor BB (PDGF-BB), angiotensin II (Ang II), and arginine vasopressin (AVP) on p27 expression.
  • To elucidate the relationship between p27 regulation and VSMC proliferation/hypertrophy.

Main Methods:

  • Cultured VSMCs were rendered quiescent by serum deprivation.
  • Cells were stimulated with Ang II, AVP, and PDGF-BB.
  • Cell cycle distribution and p27 protein expression were analyzed using flow cytometry.

Main Results:

  • Ang II significantly increased VSMC protein content (hypertrophy) but did not alter p27 levels.
  • AVP showed a slight downregulation of p27 expression.
  • PDGF-BB significantly inhibited p27 expression, leading to VSMC hyperplasia.

Conclusions:

  • PDGF-BB-induced inhibition of p27 is a key mechanism driving VSMC proliferation.
  • Ang II promotes VSMC hypertrophy independently of p27 downregulation.
  • Targeting p27 regulation may offer therapeutic strategies for vascular remodeling.

More Related Videos

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...